Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy

Chronic heart failure (CHF) is a major contributor to cardiovascular disease and is the leading cause of hospitalization for those over the age of 65, which is estimated to account for close to seventy billion dollars in healthcare costs by 2030 in the US alone. The successful therapies for preventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Samuel, T. Jake, Rosenberry, Ryan P., Lee, Seungyong, Pan, Zui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979534/
https://www.ncbi.nlm.nih.gov/pubmed/29621141
http://dx.doi.org/10.3390/ijms19041086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979534/
https://www.ncbi.nlm.nih.gov/pubmed/29621141
http://dx.doi.org/10.3390/ijms19041086

Ejemplares similares